Queen Mary University of London

The firm will hold the intellectual property for its cell capture and analysis technology as QMUL files patents for recent findings using the Parsortix system.

The International Mouse Phenotyping Consortium has systematically studied knockout mice to find new disease models and candidate disease genes.

New research has identified circulating cell subtypes with ties to better or worse outcomes in individuals with prostate cancer.

DNA methylation changes at two markers can differentiate anal cancer and high-grade anal intraepithelial neoplasms from low-grade and benign samples.

A number of these loci were linked to blood pressure medication targets, and the researchers developed a genetic risk score.

British researchers examined ash dieback disease susceptibility markers among ash trees in the UK and continental Europe.

Exome sequencing data for hundreds of testicular germ cell tumor patients led to the discovery of rare mutations affecting cilia-microtubule genes.

Tapping data for hundreds of thousands of individuals, three teams uncovered overlaps between blood pressure and other metabolic and immune traits.

Investigators looked at potential health impacts for the rare, homozygous loss-of-function mutations they detected in 3,200 British-Pakistani individuals.

Three Markers

A Queen Mary University of London-led team reports on a three-protein biomarker panel for early stage pancreatic cancer.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.